FN Media Group Presents GlobalInvestmentDaily.com Market Commentary
LONDON, Nov. 5, 2021 /PRNewswire/ -- There's a massive announcement set to take place later this year, and it could change the $12 trillion healthcare industry forever. Over the last 2 years, we've seen a huge transformation as businesses across nearly every industry have gone digital. And with the health crisis sweeping the globe last year, the healthcare sector was no different. Mentioned in today's commentary includes: Brookfield Renewable Partners L.P. (NYSE: BEP), LifeStance Health Group, Inc. (NASDAQ: LFST), Teladoc Health, Inc. (NYSE: TDOC), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), American Well Corporation (NYSE: AMWL).
- Today, over 1 billion people Google their health conditions every day, seeking out information on their symptoms before calling their doctor.
- Wellness apps have become the most downloaded in the app store, with 1.2 billion downloads throughout 2020.
- And the rise of telemedicine has brought doctors' visits to the comfort of your own home, as this trend has grown 46% from 2019 to 2020.
That's why we're now on the verge of a healthcare revolution, set to leverage the latest technology to disrupt a bloated and complicated system.
The New York Times says, "Artificial intelligence could transform medicine." Forbes predicts, "Artificial intelligence (AI) is poised to change the healthcare [...] industry in ways we couldn't have imagined only years ago." And even Big Tech giants are becoming healthcare companies, as Microsoft acquired the healthcare AI company, Nuance, for $19.7 billion earlier this year.
That makes it Microsoft's second-largest acquisition in history, which should give us a clue as to how important this shift in the healthcare system could become. But one small company with a big company vision, could soon play a major role in this healthcare revolution, as they're finally set to release their new technology after 5 years in the making.
Treatment.com International (TRUE; TREIF) brought together over 40 world-class medical experts from around the world to create the global library of medicine driven by a unique AI system that can think like a real doctor.
Now, the company is set to release it to the world in the coming months. And with its sophisticated AI symptom assessment and tracking tool, this could soon be one of the biggest developments to the healthcare system in years.
The Breakthrough Tech Trained To Think Like A Doctor
Treatment.com's new Intelligent AI Driven Digital Assistant in Cara, on the other hand, sorts through millions of pieces of data to deliver the most accurate information.
Cara will help patients to not only understand what their symptoms mean and what they're mostly likely facing…It will also help people and their caregivers monitor and track those symptoms over time.
Add to that the ability to receive personalized support and follow-up over time, and it could become an essential tool in this new healthcare revolution. With the help of world-class medical experts and engineers, they've created a unique new way to support better health and to provide access for anyone to enjoy.
Driving Recurring Revenue From New Angles?
Cara will also offer recommendations to other paid products and services like telemedicine, specialists, pharmacies, and other health products when appropriate for that next level of care. This will also provide Treatment.com with another form of revenue through referral income.
The company can also license out the AI technology to medical clinics and academic institutions like they have at the University of Minnesota. They've already tested the software in busy clinics, and it's showing promise in helping to streamline visits to save time and improving the accuracy of diagnoses for patients. With AI set to transform the $12 trillion healthcare system, it could soon pay massive dividends as Treatment.com is set to release the Cara app later this year.
Treatment.com (TRUE; TREIF) is now set to release the Cara app in the coming months, which could provide a major catalyst for Treatment.com to add its name as a major player in the industry in 2022 and beyond.
Tech is bringing the world into the future:
It's no secret. The world is going to be running on renewables in just a few decades. And Brookfield Renewable Partners LP (BEP) is one of the companies leading the charge. Brookfield is a global giant when it comes to renewables, and hydrogen is its newest game. This time last year, Brookfield joined forces with one of the most exciting pure-play hydrogen fuel cell stocks, Plug Power (PLUG). PLUG has had its ups and down, and might now be entering another new phase of reward for investors, but it's Brookfield that is the steady climber in the sector.
Brookfield is already looking to community solutions, including a first of its kind solar partnership in Washington D.C. And it's addressing other issues, including a major clean water initiative in Brazil - something that will indirectly help keep people healthy for years to come.
Lifestance Health Group Inc (LFST) is a company that looks beyond profitability, as well. It is a company that truly cares about the well-being of the world. Recently, Lifestance Health Group donated a significant chunk of change to the U.S. Paralympic Foundation and another donation to the Mental Health Coalition. Mike Lester, Director, LifeStance Health Foundation, said in a release, "Unifying physical and mental health is critically important for all of us, and we stand in support of elite athletes like Simone Biles and Naomi Osaka encouraging the destigmatization of mental health and speaking openly about their own challenges."
Lifestance Health is a company that provides healthcare services to individuals and families in the United States. The company has experienced rapid growth since its founding, with a focus on improving patient outcomes and efficiency of care delivery. Lifestance Health Group continues to innovate by investing in emerging technologies like artificial intelligence (AI) and machine learning (ML). Lifestance's mission is "to provide access to quality health care for all."
In early October, Health Inc (TDOC), announced that its primary care service, Primary360, will be available to commercial health plans, employers, and other organizations that sponsor health care for individuals and families in the United States. This is huge because it will open the door to a massive amount of people who may have otherwise fallen between the cracks.
"Primary360 has the unique power to drive the unified health care experience that consumers are demanding by removing longstanding barriers like access, cost and convenience," adding "Primary360 gives people greater control over their healthcare experience without losing the personal connection they seek – all from a brand that they trust," Donna Boyer, chief product officer at Teladoc Health, explained.
On October 5th, Mind Medicine (MindMed) Inc (MNMD) announced a major partnership with Sphere Health to launch a new study harnessing existing consumer technology to build an exciting new data set which could be used to create more efficient machine learning tools to potentially show association with and predict symptoms of mental health issues such as anxiety and depression.
"We are thrilled to have Sphere Health as a partner in this endeavor. As the ways in which individuals use technology to access care continues to evolve, so can our understanding of mental illness and mental health. The use of technology has the potential to offer a level of sensitivity and precision which does not currently exist in our models of these disorders and, we hope, will ultimately lead to better outcomes in our ability to help the folks who suffer from them" Daniel R. Karlin, MD MA, Chief Medical Officer of MindMed, explained.
American Well Corp (AMWL) is another company betting big on video and voice services in the healthcare industry. American Well Corp. has its sights set on the future of medication. In fact, a recent survey on the topic conducted by the company suggests that tha decision makers in hospitals, clinicians, and more are looking at telehealth becoming a permanent fixture for care delivery moving forward.
Ido Schoenberg, Chairman and Co-CEO, American Well Corp. explained, "During the pandemic, telehealth proved to be a critical, and in many cases the only connection point between patients and care teams. For many organizations that meant launching and scaling telehealth as quickly as possible."
By. John Atronis
** IMPORTANT NOTICE AND DISCLAIMER -- PLEASE READ CAREFULLY! **
This article is a paid advertisement. GlobalInvestmentDaily.com and its owners, managers, employees, and assigns (collectively "the Publisher") is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher has been compensated by Treatment.com International Inc. ("Treatment.com" or "Company") to conduct investor awareness advertising and marketing. Treatment.com paid the Publisher four hundred and fifty thousand US dollars to produce and disseminate four articles profiling the Company. This compensation should be viewed as a major conflict with our ability to be unbiased.
Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price may likely occur.
This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company's SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and on interviews with company management, and does not (to the Publisher's knowledge, as confirmed by Treatment.com) contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information.
SHARE OWNERSHIP. The Publisher owns shares and / or options of the featured company and therefore has an additional incentive to see the featured company's stock perform well. The Publisher does not undertake any obligation to notify the market when it decides to buy or sell shares of the issuer in the market. The Publisher will be buying and selling shares of the featured company for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.
FORWARD LOOKING STATEMENTS. This publication contains forward-looking information which is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ from those projected in the forward-looking statements. Forward looking statements in this publication include, but are not limited to, the size and anticipated growth of the market for the companies' products, the prospects for success of the Company's to be launched health and wellness app – "CARA", the reported scheduled release of CARA, the ability to acquire customers for CARA, and the projected growth and profit margins of the Company's core product offerings. Factors that could cause results to differ include, but are not limited to, the companies' ability to fund its capital requirements in the near term and long term, the management team's ability to effectively execute its strategy, the degree of success of the launch of CARA, competition, market saturation, pricing pressures, etc. The forward-looking information contained herein is given as of the date hereof and we assume no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.
INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Publisher, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
INTELLECTUAL PROPERTY. GlobalInvestmentDaily.com is the Publisher's trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Publisher is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks.
DISCLAIMER: GlobalInvestmentDaily.com is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with GlobalInvestmentDaily.com or any company mentioned herein. The commentary, views and opinions expressed in this release by GlobalInvestmentDaily.com are solely those of GlobalInvestmentDaily.com and are not shared by and do not reflect in any manner the views or opinions of FNM. FNM is not liable for any investment decisions by its readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Media Contact e-mail: email@example.com U.S. Phone: +1(954)345-0611